The Top 25 Healthcare Technology CEOs of Asia for 2020

The Healthcare Technology Report is pleased to announce The Top 25 Healthcare Technology CEOs of Asia for 2020. The healthcare technology industry is facing more pressure than ever before as the demand for new treatments, devices, and digital solutions reaches new heights. Strong and inventive leadership is needed in order for companies to keep up with this evolving market, and the CEOs represented on this year’s list exemplify both of those qualities and more. They have successfully guided their companies to become leaders in their fields, in both Asia and the global healthcare technology sector while fostering growth and innovation within their workforces.

Among this year’s notable achievements, Dharmil Sheth has seen his company PharmEasy double its business each year to become one of the largest pharmaceutical technology platforms in the industry. Similarly, DXY has seen four successful funding rounds under the guidance of CEO Jin Zhang, totaling $182 million in funding raised to date. These accomplishments demonstrate the expert strategy employed by these leaders in developing products and services that are not only financially promising, but also widely beneficial to the health of populations around the world.

Through their dedication to improving global health, their ability to build and guide their organizations, and their specific domains of expertise, these individuals have made their mark. The Healthcare Technology Report team celebrates the achievements of this year’s Top 25 Healthcare Technology CEOs of Asia for 2020.

Congratulations to each of this year’s awardees.

David Chang (WuXi AppTec), Peter DeYoung (Piramal Group), John Oyler (BeiGene), Sanjiv Navangul (Bharat Serums and Vaccines), Shashank ND (Practo), Alex Li (United Imaging Healthcare), Dharmil Sheth (PharmEasy), Jonathan Sudharta (Halodoc), Tushar Vashisht (HealthifyMe), Vedam Ramprasad (MedGenome), Deepak Sahni (Healthians), Prashant Jhaveri (MediBuddy), Jin Zhang (DXY), Toru Nishikawa (Preferred Networks), Michelle Xia (Akeso Biopharma), Mukesh Parmar (Docplexus), Avi Lasarow (Prenetics), Silviu Itescu (Mesoblast), Minhong Jang (Lunit), Jingsong Wang (Harbour BioMed), Colin Denver (SpeeDx), Shailesh Prithani (Doxper), Li Chen (Hua Medicine), Daniel Carraway (RWDC Industries), and Sudhir Srivastava (SS Innovations).

About The Healthcare Technology Report

The Healthcare Technology Report provides market research and insights, business news, investment activity updates and important corporate developments related to the healthcare technology sector. Based in New York City, the firm is run by a seasoned team of editors, writers and media professionals highly knowledgeable on healthcare technology and the various companies, executives and investors that make up the sector.

Share article on social media or email:

Leave a Reply